Product Information
- Ilaris
- Canakinumab
- ACZ 885
Canakinumab is a human monoclonal antibody that binds to interleukin-1β and inhibits its biological activity, which is involved in the pathogenesis of various autoimmune diseases. Canakinumab has been shown to be effective in the treatment of chronic arthritis, long-term efficacy, and toxicological studies. The compound also reduces the activity index in patients with congestive heart failure or bowel disease. Canakinumab does not inhibit cyclooxygenase enzymes and does not have anti-inflammatory properties.
Chemical properties
Technical inquiry about: 3D-BC176794 Canakinumab - in PBS buffer approx. 15mg/ml
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
